Log in to save to my catalogue

High-throughput mutagenesis identifies mutations and RNA-binding proteins controlling CD19 splicing...

High-throughput mutagenesis identifies mutations and RNA-binding proteins controlling CD19 splicing...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_c08d347a8dc943b8ab905da6ad76b36d

High-throughput mutagenesis identifies mutations and RNA-binding proteins controlling CD19 splicing and CART-19 therapy resistance

About this item

Full title

High-throughput mutagenesis identifies mutations and RNA-binding proteins controlling CD19 splicing and CART-19 therapy resistance

Publisher

London: Nature Publishing Group UK

Journal title

Nature communications, 2022-09, Vol.13 (1), p.5570-5570, Article 5570

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Following CART-19 immunotherapy for B-cell acute lymphoblastic leukaemia (B-ALL), many patients relapse due to loss of the cognate CD19 epitope. Since epitope loss can be caused by aberrant
CD19
exon 2 processing, we herein investigate the regulatory code that controls
CD19
splicing. We combine high-throughput mutagenesis with mathemati...

Alternative Titles

Full title

High-throughput mutagenesis identifies mutations and RNA-binding proteins controlling CD19 splicing and CART-19 therapy resistance

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_c08d347a8dc943b8ab905da6ad76b36d

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_c08d347a8dc943b8ab905da6ad76b36d

Other Identifiers

ISSN

2041-1723

E-ISSN

2041-1723

DOI

10.1038/s41467-022-31818-y

How to access this item